Eli Lilly and Co.
Eli Lilly and Co. is a prominent U.S. pharmaceutical company known for its innovative research and development in various therapeutic areas, including diabetes, oncology, and immunology. Recently, the company has been in the news for its new drug, orforglipron, which showed promising results in clinical trials for weight loss and blood sugar reduction, positioning it as a competitor to the widely used Ozempic.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Eli Lilly and Co. is a U.S. pharmaceutical company that is developing a new weight-loss drug.
5